Healthcare API Market Size, Growth, Trends | Report 2022-2030
The global healthcare API market was surpassed at USD 103.86 million in 2021 and is expected to hit around USD 337.01 million by 2030, growing at a CAGR of 13.97% from 2022 to 2030.
Report Highlights
Increasing demand for healthcare integration and adoption of Application Programming Interfaces (APIs) by the HCOs are the major factors driving the growth of the market.
Factors such as technological advancements in health care solutions and the co-existence of healthcare and IT services are expected to continue driving the adoption of healthcare API. It allows patients to get well acquainted with the doctors or specialist’s details and appointment suggestions. Increasing focus towards the adoption of the Internet of Things (IoT) and Remote Patient Monitoring (RPM) is expected to drive the market growth in the forthcoming years.
Industry players are trying to develop a fully integrated API solution to gain market penetration. Moreover, the COVID-19 pandemic has increased the need for remote access to patients’ data which is expected to boost the growth of the market. For instance, in May 2020, Change Healthcare launched a suite of solutions such as industry-standard APIs, hardware bundle, and software solutions in order to help telemedicine providers to deploy virtual care services.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 103.86 million |
| Revenue Forecast by 2030 | USD 337.01 million |
| Growth rate from 2022 to 2030 | CAGR of 13.97% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Services, deployment, end-use, region |
| Companies Covered | Practo Technologies Pvt. Ltd.; Apple, Inc.; General Electric Company; Athenahealth; Cerner Corporation; Microsoft Corporation; Epic Systems Corporation; eClinical Works LLC; Allscripts Healthcare Solutions Inc.; Greenway Health, LLC; Practice Fusion, Inc.; MuleSoft, Inc. |
Services Insights
On the basis of services, the healthcare API market is segmented into EHR access, appointments, remote patient monitoring, payment, and wearable medical devices. EHR access dominated the market with a revenue share of over 30.4% in 2021. API can easily integrate the EHR with other platforms which will help seamless data integration with the third parties. Moreover, the EHR vendors are actively building APIs in their platform to provide value-based patient care which is further increasing the adoption. For instance, in February 2021 Microsoft Azure launched cloud-based API for FHIR standard for better interoperability and data sharing.
The remote patient monitoring segment is expected to exhibit the fastest growth over the forecast period. Connected health and remote patient monitoring gain much attention during the COVID-19 pandemic as doctors and caregivers need to treat patients remotely in order to reduce the risk of contamination. The providers are offering various patient engagement platforms with integrated API for better treatment options and guidance based on their past medical records.
Deployment Model Insights
On the basis of mode of deployment, the healthcare application programming interface market can be segmented into cloud-based API and on premise-based API. The cloud-based API held the largest market share of around 80.5% in 2021. The growth can be attributed to the availability of free storage space to store and organize healthcare data of patients and hospitals that is easily accessible during emergencies by healthcare professionals and caregivers.
The on-premise healthcare application programming interface also held a considerable revenue share in 2021 owing to its associated advantages such as data privacy and security. This restricts data breaching as they have entire control over the healthcare software. Furthermore, the installation of the software is convenient and the stored data can be utilized for future re-processing.
End-use Insights
On the basis of end-use, the market can be segmented into healthcare providers, patients, healthcare payers, and vendors. Providers segment held the largest revenue with a revenue share of over 47.07% in 2021. The healthcare providers segment comprises hospitals, clinics, and other organizations. The incorporation of healthcare API in hospitals has propelled the segment growth. API stores medical records, patient information, healthcare data, and patient history which can be easily accessible during an emergency.
The healthcare payers segment is expected to showcase lucrative growth over the forecast period. A customized workflow created by the integrated API ensures easy approval and review of the desired data by healthcare payers and caregivers. API also allows easy patient billing and management of patient appointments. The payers can securely get access to patients’ health records and bills without unwanted phone calls and going through receptionists.
Region Insights
North America dominated the market with a revenue share of around 35.09% in 2021. This growth can be attributed to various factors such as favorable policies for deployment of healthcare application programming interface and high digital literacy rates. Moreover, the presence of established healthcare infrastructure with integrated EHR of patients is another major growth propelling factor for the market. Increase number of adopters such as big HCOs in the U.S. is expected to further drive the regional demand.
Europe is expected to exhibit the fastest CAGR over the forecast period owing to the established healthcare infrastructure in this region and the advent of the Internet of Things (IoT) and related technologies. The General Data Protection Regulation (GDPR) was implemented on May 25th, 2020 in the European Union, which is a law on data privacy and protection. The law is more stringent than that of the U.S., HIPAA, and addresses the personal export of data outside the European countries, which is expected to increase the adoption of healthcare API.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Healthcare API Market
5.1. COVID-19 Landscape: Healthcare API Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Healthcare API Market, By Services
8.1. Healthcare API Market, by Services, 2022-2030
8.1.1 EHR Access
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Appointments
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Remote Patient Monitoring
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Payment
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Wearable Medical Device
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Healthcare API Market, By Deployment Model
9.1. Healthcare API Market, by Deployment Model, 2022-2030
9.1.1. Cloud-based
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. On-Premise
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Healthcare API Market, By End-use
10.1. Healthcare API Market, by End-use, 2022-2030
10.1.1. Healthcare Payers
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Providers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Patients
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Vendors
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Healthcare API Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Services (2017-2030)
11.1.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.1.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.2.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Services (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.3.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Services (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Services (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.5.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Services (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Services (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Deployment Model (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 12. Company Profiles
12.1. Practo Technologies Pvt. Ltd.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Apple, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. General Electric Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Athenahealth
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cerner Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Microsoft Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Epic Systems Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinical Works LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Allscripts Healthcare Solutions Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Greenway Health, LLC
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers